Scwf.Kl

SCWF.KL's capital structure is characterized by a debt-to-equity ratio of 0.82, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.01, suggesting limited short-term liquidity cushion. Free cash flow is negative at -8.59 million MYR, and operating cash flow is also negative at -5.34 million MYR, signaling cash flow constraints.

Profitability metrics show significant underperformance relative to industry norms. Return on equity is -26.72%, and return on assets is -7.04%, both well below the typical thresholds for a healthy chemical company. Gross profit of 16.88 million MYR is insufficient to cover operating expenses, as evidenced by an operating loss of -8.73 million MYR. The company's net loss of -11.18 million MYR further underscores its financial distress.

Geographic and segment exposure is not explicitly detailed in the available data, but the company's revenue concentration is likely tied to its domestic operations in Malaysia, given the absence of international revenue breakdowns. The lack of segment reporting limits visibility into the performance of individual product lines or geographic regions.

Growth trajectory is negative, with no clear signs of improvement in the near term. The company reported a net loss and negative cash flows, and there are no disclosed plans for significant revenue growth or cost reductions. Capital expenditures of -629,260 MYR are minimal, suggesting limited investment in future capacity or innovation.

Risk factors include liquidity constraints and a high probability of continued operating losses. The company's net cash position is negative after subtracting total debt, and its liquidity risk is rated as medium. Dilution risk is currently low, but the company's financial position could deteriorate further, potentially leading to equity issuance. The absence of a clear turnaround strategy increases the risk of further financial distress.

Recent events include the disclosure of a net loss and negative cash flows in the latest financial report. Analyst estimates for revenue and EPS are significantly lower than the company's historical performance, indicating a lack of confidence in its near-term prospects. No recent filings or transcripts suggest a strategic shift or capital restructuring.